NCT05110391View on ClinicalTrials.gov

Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy

CompletedOBSERVATIONAL

Enrollment

616

Participants

Timeline

Start Date

February 1, 2014

Primary Completion Date

September 15, 2021

Study Completion Date

September 15, 2021

Conditions

Non-obstructive AzoospermiaHormone DeficiencyHypogonadism, MaleMale Infertility

Interventions

DRUG

Hormonal Therapy Agent

Consecutive patients with NOA and hypogonadism (defined by baseline total testosterone levels equal or below 350 ng/dL) subjected to microdissection testicular sperm extraction who received or not pre-sperm retrieval gonadotropin therapy.

Trial Locations (1)

13075-460

Androfert, Campinas

All Listed Sponsors

lead

ANDROFERT - Clinica de Andrologia e Reproducao Humana

OTHER

NCT05110391 - Sperm Retrieval Rates in Non-obstructive Azoospermic Men Subjected to Gonadotropin Therapy | Biotech Hunter | Biotech Hunter